Skip to main content
Erschienen in: Herz 3/2014

01.05.2014 | Original article

The HATCH and CHA2DS2-VASc scores

Prognostic value in pulmonary vein isolation

verfasst von: E.U. Schmidt, R. Schneider, MD, J. Lauschke, MD, I. Wendig, D. Bänsch, MD, PHD

Erschienen in: Herz | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims

The HATCH score describes the risk of paroxysmal atrial fibrillation (Afib) progression, while the CHA2DS2vasc score depicts the risk of thromboembolic events in patients with Afib. We hypothesized that both scores may predict failure of Afib ablation.

Methods and results

In all, 449 consecutive patients (65.5 % male, mean age 61.7 ± 10.1 years) who presented to our institution for Afib ablation were investigated. A HATCH score of 0, 1, 2, 3, and ≥ 4 was found in 19.6, 50.3, 9.8, 15.6, and 4.6 % of the patients, respectively. A CHA2DS2vasc score of 0, 1, 2, 3, 4, 5, and > 5 was found in 10.7, 20.9, 25.1, 20.6, 15.0, 4.7, and 3.0 % of the patients, respectively (mean CHA2DS2vasc score, 2.4 ± 1.5). After 618 procedures (1.38 ± 0.55/patient), 84.3 % of patients were free of any atrial arrhythmia after a mean follow-up of 12.7 ± 7.1 months. The freedom of Afib after a single ablation procedure ranged between 50.7 and 60.3 % in patients with HATCH scores between 0 and 3 and dropped to 30.0 % in patients with a HATCH score greater than 3 (p = 0.041). The freedom of Afib after 1.38 procedures per patient ranged between 79.5 % and 88.4 % in patients with a HATCH score between 0 and 3 and was lower with a score of 4 or more (66.7 %, p = 0.064). Pulmonary vein isolation was equally successful in patients with a CHA2DS2vasc score of 5 or lower, but less effective in patients with a score greater than 5 (p = 0.013).

Conclusion

Pulmonary vein isolation is equally effective in patients with a low-to-moderate risk of disease progression and thromboembolic risk. However, the success rate seems to decrease in patients with high sores.
Literatur
1.
Zurück zum Zitat Vos CB de, Pisters R, Nieuwlaat R et al (2010) Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55(8):725–731PubMedCrossRef Vos CB de, Pisters R, Nieuwlaat R et al (2010) Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 55(8):725–731PubMedCrossRef
2.
Zurück zum Zitat Olesen JB, Lip GYH, Hansen ML et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. Br Med J 342 Olesen JB, Lip GYH, Hansen ML et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. Br Med J 342
3.
Zurück zum Zitat Olesen JB, Torp-Pedersen C, Hansen ML, Lip GYH (2012) The value of the CHA(2)DS(2)-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS(2) score 0–1: a nationwide cohort study. Thromb Haemost 107(6):1172–1179PubMedCrossRef Olesen JB, Torp-Pedersen C, Hansen ML, Lip GYH (2012) The value of the CHA(2)DS(2)-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS(2) score 0–1: a nationwide cohort study. Thromb Haemost 107(6):1172–1179PubMedCrossRef
4.
Zurück zum Zitat Camm AJ, Lip GYH, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 33(21):2719–2747PubMedCrossRef Camm AJ, Lip GYH, De Caterina R et al (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 33(21):2719–2747PubMedCrossRef
5.
Zurück zum Zitat Camm AJ, Camm CF, Savelieva I (2012) Medical treatment of atrial fibrillation. J Cardiovasc Med 13(2):97–107CrossRef Camm AJ, Camm CF, Savelieva I (2012) Medical treatment of atrial fibrillation. J Cardiovasc Med 13(2):97–107CrossRef
6.
Zurück zum Zitat Camm J (2012) Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits. Int J Cardiol 155(3):362–371PubMedCrossRef Camm J (2012) Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits. Int J Cardiol 155(3):362–371PubMedCrossRef
7.
Zurück zum Zitat Natale A, Raviele A, Al Ahmad A et al (2010) Venice chart international consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol 21(3):339–379PubMedCrossRef Natale A, Raviele A, Al Ahmad A et al (2010) Venice chart international consensus document on ventricular tachycardia/ventricular fibrillation ablation. J Cardiovasc Electrophysiol 21(3):339–379PubMedCrossRef
8.
Zurück zum Zitat Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. Eur Heart J 27(17):2099–2140PubMedCrossRef Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary. Eur Heart J 27(17):2099–2140PubMedCrossRef
9.
Zurück zum Zitat Bunch TJ, Crandall BG, Weiss JP et al (2011) Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 22(8):839–845PubMedCrossRef Bunch TJ, Crandall BG, Weiss JP et al (2011) Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 22(8):839–845PubMedCrossRef
10.
Zurück zum Zitat Hunter RJ, McCready J, Diab I et al (2012) Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 98(1):48–53PubMedCrossRef Hunter RJ, McCready J, Diab I et al (2012) Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 98(1):48–53PubMedCrossRef
11.
Zurück zum Zitat Park JH, Joung B, Son NH et al (2011) The electroanatomical remodelling of the left atrium is related to CHADS(2)/CHA(2)DS(2)VASc score and events of stroke in patients with atrial fibrillation. Europace 13(11):1541–1549PubMedCrossRef Park JH, Joung B, Son NH et al (2011) The electroanatomical remodelling of the left atrium is related to CHADS(2)/CHA(2)DS(2)VASc score and events of stroke in patients with atrial fibrillation. Europace 13(11):1541–1549PubMedCrossRef
12.
Zurück zum Zitat Ouyang FF, Bansch D, Ernst S et al (2004) Complete isolation of left atrium surrounding the pulmonary veins—new insights from the double-lasso technique in paroxysmal atrial fibrillation. Circulation 110(15):2090–2096PubMedCrossRef Ouyang FF, Bansch D, Ernst S et al (2004) Complete isolation of left atrium surrounding the pulmonary veins—new insights from the double-lasso technique in paroxysmal atrial fibrillation. Circulation 110(15):2090–2096PubMedCrossRef
13.
Zurück zum Zitat Ouyang F, Ernst S, Chun J et al (2005) Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double lasso catheter technique. Circulation 112(20):3038–3048PubMedCrossRef Ouyang F, Ernst S, Chun J et al (2005) Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double lasso catheter technique. Circulation 112(20):3038–3048PubMedCrossRef
14.
Zurück zum Zitat Kerr CR, Humphries KH, Talajic M et al (2005) Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial-fibrillation: results from the Canadian registry of atrial fibrillation. Am Heart J 149(3):489–496PubMedCrossRef Kerr CR, Humphries KH, Talajic M et al (2005) Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial-fibrillation: results from the Canadian registry of atrial fibrillation. Am Heart J 149(3):489–496PubMedCrossRef
15.
Zurück zum Zitat Jongnarangsin K, Suwanagool A, Chugh A et al (2012) Effect of catheter ablation on progression of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 23(1):9–14PubMedCrossRef Jongnarangsin K, Suwanagool A, Chugh A et al (2012) Effect of catheter ablation on progression of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 23(1):9–14PubMedCrossRef
16.
Zurück zum Zitat Tang RB, Dong JZ, Long DY et al (2012) Efficacy of catheter ablation of atrial fibrillation beyond HATCH score. Chin Med J (Engl) 125(19):3425–3429 (Ref Type: Abstract) Tang RB, Dong JZ, Long DY et al (2012) Efficacy of catheter ablation of atrial fibrillation beyond HATCH score. Chin Med J (Engl) 125(19):3425–3429 (Ref Type: Abstract)
17.
Zurück zum Zitat Koide Y, Yotsukura M, Sakata K et al (2002) Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation. Clin Cardiol 25(2):69–75PubMedCrossRef Koide Y, Yotsukura M, Sakata K et al (2002) Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation. Clin Cardiol 25(2):69–75PubMedCrossRef
18.
Zurück zum Zitat Ouyang FF, Antz M, Ernst S et al (2005) Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins—lessons from double lasso technique. Circulation 111(2):127–135PubMedCrossRef Ouyang FF, Antz M, Ernst S et al (2005) Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins—lessons from double lasso technique. Circulation 111(2):127–135PubMedCrossRef
Metadaten
Titel
The HATCH and CHA2DS2-VASc scores
Prognostic value in pulmonary vein isolation
verfasst von
E.U. Schmidt
R. Schneider, MD
J. Lauschke, MD
I. Wendig
D. Bänsch, MD, PHD
Publikationsdatum
01.05.2014
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 3/2014
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-3835-x

Weitere Artikel der Ausgabe 3/2014

Herz 3/2014 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.